A prospective study of semen quality and fecundability among North American couples planning pregnancy
Andrology · 2026
DOI: 10.1111/andr.70084 ↗At a glance
Journal article in Andrology, 2026. Written by Sharonda M Lovett and 7 co-authors. Institution: Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA. Major MEDLINE topics: Semen Analysis, Fertility. Cited 3 times so far (Crossref); 73 references. The full text is freely available in PubMed Central. Funded by: NICHD NIH HHS, NIH, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (original language)
Background
Few studies have prospectively evaluated semen quality (using the most up‐to‐date clinically relevant definitions) and fecundability (the per‐cycle probability of conception).
Objective
To study semen quality in relation to fecundability. Materials and methods We analyzed prospectively collected data from 763 male participants aged ≥21 years from Pregnancy Study Online (PRESTO), a North American preconception cohort study (2015–2024). Eligible participants for the semen testing substudy resided in the contiguous United States, had been attempting conception for ≤6 cycles at cohort entry, and had a female partner aged 21–45 years with regular menses. Participants used an at‐home semen testing device to measure semen volume, sperm concentration, and motile sperm concentration. Participants contributed up to two semen tests during the preconception period (1376 total semen samples). We calculated sperm motility, total sperm count, and total motile sperm count. We evaluated results according to 2021 World Health Organization (WHO)‐defined thresholds for low semen quality. Female participants reported their pregnancy status on bimonthly follow‐up questionnaires for up to 12 cycles or until conception, whichever came first. We used proportional probabilities regression models to estimate fecundability ratios (FRs) and 95% confidence intervals (CIs), adjusting for potential confounders.
Results
After accounting for censoring using life‐table methods, 80.7% of couples conceived within 12 cycles. FRs were 1.48 (95% CI, 1.05–2.08) for low semen volume (≤1.5 vs. >1.5 mL), 0.74 (95% CI, 0.56–0.97) for low sperm concentration (≤16 vs. >16 million/mL), 0.98 (95% CI, 0.81–1.19) for low sperm motility (≤42 vs. >42%), 0.58 (95% CI, 0.38–0.88) for low total sperm count (≤39 vs. >39 million), and 0.73 (95% CI, 0.52–1.04) for low total motile sperm count (≤21 vs. >21 million). Associations between low total motile sperm count and fecundability were stronger among couples with
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.
- Laboratory Corporation of America, Pleasanton, California, USA.
- Department of Urology, Stanford University School of Medicine, Stanford, California, USA.
ORCID profiles: Sharonda M Lovett, Amelia K Wesselink, Lauren A Wise
Funding
- NICHD NIH HHS
- NIH
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institutes of Health
Cite
APA
Lovett, S. M., Sommer, G. J., Krivorotko, D., Wesselink, A. K., Rothman, K. J., Hatch, E. E., Eisenberg, M. L., & Wise, L. A. (2026). A prospective study of semen quality and fecundability among North American couples planning pregnancy. Andrology. https://doi.org/10.1111/andr.70084
Vancouver
Lovett SM, Sommer GJ, Krivorotko D, Wesselink AK, Rothman KJ, Hatch EE, et al. A prospective study of semen quality and fecundability among North American couples planning pregnancy. Andrology. 2026. doi:10.1111/andr.70084
BibTeX
@article{Lovett2026,
author = {Lovett, Sharonda M and Sommer, Greg J and Krivorotko, Dmitrii and Wesselink, Amelia K and Rothman, Kenneth J and Hatch, Elizabeth E and Eisenberg, Michael L and Wise, Lauren A},
title = {A prospective study of semen quality and fecundability among North American couples planning pregnancy},
journal = {Andrology},
year = {2026},
doi = {10.1111/andr.70084}
}
EUVIMED